{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:34:30Z","timestamp":1793450070898,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32400777"],"award-info":[{"award-number":["32400777"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB0490000"],"award-info":[{"award-number":["XDB0490000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M782847"],"award-info":[{"award-number":["2025M782847"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.virs.2026.09.014","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:49:34Z","timestamp":1791528574000},"page":"1213-1226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A dual-glycoprotein-targeting bispecific nanoantibody confers potent neutralization against Nipah virus"],"prefix":"10.1016","volume":"41","author":[{"given":"Shengdong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guibo","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-8925","authenticated-orcid":false,"given":"Sheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9034-5755","authenticated-orcid":false,"given":"Sandra","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-5642","authenticated-orcid":false,"given":"Rui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6304-9738","authenticated-orcid":false,"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2026.09.014_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.09.014_bib2","first-page":"1","article-title":"Analysis of the binding loops configuration and surface adaptation of different crystallized single-domain antibodies in response to various antigens","volume":"30","author":"Al Qaraghuli","year":"2016","journal-title":"J. Mol. Recogn."},{"key":"10.1016\/j.virs.2026.09.014_bib3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/infdis\/jiv449","article-title":"Escape from monoclonal antibody neutralization affects Henipavirus fitness in vitro and in vivo","volume":"213","author":"Borisevich","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.09.014_bib4","article-title":"Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.09.014_bib5","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.virs.2026.09.014_bib6","article-title":"Discovery of novel anti-serum albumin VHH as a building block for PK prolongation","volume":"6","author":"Chen","year":"2023","journal-title":"Antibody Ther."},{"key":"10.1016\/j.virs.2026.09.014_bib7","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41594-019-0308-9","article-title":"An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections","volume":"26","author":"Dang","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virs.2026.09.014_bib8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41594-021-00584-8","article-title":"Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins","volume":"28","author":"Dang","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virs.2026.09.014_bib9","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.0505379103","article-title":"Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies","volume":"103","author":"De Genst","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.09.014_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2018.05.015","article-title":"Enhancing preparation for large Nipah outbreaks beyond Bangladesh: preventing a tragedy like Ebola in West Africa","volume":"72","author":"Donaldson","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.09.014_bib11","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.cell.2020.11.023","article-title":"Potent henipavirus neutralization by antibodies recognizing diverse sites on Hendra and Nipah Virus receptor binding protein","volume":"183","author":"Dong","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.virs.2026.09.014_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109628","article-title":"Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein","volume":"36","author":"Doyle","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.virs.2026.09.014_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4103\/bbrj.bbrj_104_23","article-title":"Distinct host gene targets and mode of action in the MicroRNA of Nipah virus from Malaysia and Bangladesh: a comparative in-silico based analysis","volume":"7","author":"Dsouza","year":"2023","journal-title":"Biomedical and Biotechnology Research Journal (BBRJ)"},{"key":"10.1016\/j.virs.2026.09.014_bib14","article-title":"Nipah virus in focus: a comprehensive review of the pathogenesis, epidemiological patterns, diagnostic advances, and future public health strategies","volume":"18","author":"Gurajala","year":"2026","journal-title":"Cureus"},{"key":"10.1016\/j.virs.2026.09.014_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-27610-z","article-title":"A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo","volume":"13","author":"Hanke","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.09.014_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12250-009-3027-2","article-title":"The mechanism of henipavirus fusion: examining the relationships between the attachment and fusion glycoproteins","volume":"24","author":"Hickey","year":"2009","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virs.2026.09.014_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/antib4030141","article-title":"Pre-Clinical intravenous serum pharmacokinetics of Albumin binding and non-half-life extended nanobodies\u00ae","volume":"4","author":"Hoefman","year":"2015","journal-title":"Antibodies"},{"key":"10.1016\/j.virs.2026.09.014_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/v14061162","article-title":"Single-Domain antibodies as therapeutics for respiratory RNA virus infections","volume":"14","author":"Huang","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2026.09.014_bib19","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41594-025-01598-2","article-title":"A nanobody-based therapeutic targeting Nipah virus limits viral escape","volume":"32","author":"Isaacs","year":"2025","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virs.2026.09.014_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-7-312","article-title":"A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system","volume":"7","author":"Khetawat","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.virs.2026.09.014_bib21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virs.2026.09.014_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00842","article-title":"Structure-Based design of Nipah virus vaccines: a generalizable approach to Paramyxovirus immunogen development","volume":"11","author":"Loomis","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.09.014_bib23","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1080\/21645515.2019.1627820","article-title":"In vitro and in vivo efficacy of a Rift Valley fever virus vaccine based on pseudovirus","volume":"15","author":"Ma","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virs.2026.09.014_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.csbj.2023.11.056","article-title":"Structural trends in antibody-antigen binding interfaces: a computational analysis of 1833 experimentally determined 3D structures","volume":"23","author":"Madsen","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.virs.2026.09.014_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-024-02513-3","article-title":"The pathogens that could spark the next pandemic","volume":"632","author":"Mallapaty","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.09.014_bib26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.abn7760","article-title":"SARS-CoV-2 Omicron variant: antibody evasion and cryo-EM structure of spike protein-ACE2 complex","volume":"375","author":"Mannar","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.09.014_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/v16020195","article-title":"Structural studies of henipavirus glycoproteins","volume":"16","author":"May","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2026.09.014_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150454","article-title":"Structural design of the anti-TNF\u03b1 therapeutic NANOBODY\u00ae compound, ozoralizumab, to support its potent and sustained clinical efficacy","volume":"734","author":"Mima","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virs.2026.09.014_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nature03838","article-title":"EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus","volume":"436","author":"Negrete","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.09.014_bib30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/22221751.2019.1571871","article-title":"Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities","volume":"8","author":"Nie","year":"2019","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virs.2026.09.014_bib31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.virs.2026.09.014_bib32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.09.014_bib33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1473-3099(19)30634-6","article-title":"Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study","volume":"20","author":"Playford","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2026.09.014_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.virs.2026.09.014_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1389548","article-title":"Next generation single-domain antibodies against respiratory zoonotic RNA viruses","volume":"11","author":"Swart","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.virs.2026.09.014_bib36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/mr\/road038","article-title":"Structural, nonclinical, and clinical features of ozoralizumab: a novel tumour necrosis factor inhibitor","volume":"33","author":"Takeuchi","year":"2023","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.virs.2026.09.014_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109367","article-title":"Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice","volume":"9","author":"Terryn","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.09.014_bib38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/20477724.2024.2380131","article-title":"Global and regional mortality statistics of nipah virus from 1994 to 2023: a comprehensive systematic review and meta-analysis","volume":"118","author":"Vasudevan","year":"2024","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.virs.2026.09.014_bib39","article-title":"Highly potent C-type nanoantibodies neutralize Nipah and Hendra viruses by cavity filling on fusion glycoprotein","volume":"17","author":"Wang","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.09.014_bib40","article-title":"Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.09.014_bib41","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1126\/science.abm5561","article-title":"Architecture and antigenicity of the Nipah virus attachment glycoprotein","volume":"375","author":"Wang","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.09.014_bib42","article-title":"Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variant","volume":"119","author":"Wang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.09.014_bib43","article-title":"Unraveling a three-step spatiotemporal mechanism of triggering of receptor-induced nipah virus fusion and cell entry","volume":"9","author":"Whelan","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.09.014_bib44","series-title":"Nipah Virus Infection - Bangladesh","year":"2026"},{"key":"10.1016\/j.virs.2026.09.014_bib45","series-title":"Nipah Virus Infection - India","year":"2026"},{"key":"10.1016\/j.virs.2026.09.014_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005322","article-title":"Crystal structure of the pre-fusion nipah virus fusion Glycoprotein reveals a novel hexamer-of-trimers assembly","volume":"11","author":"Xu","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.09.014_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003684","article-title":"Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody","volume":"9","author":"Xu","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.09.014_bib48","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/528801","article-title":"Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody","volume":"197","author":"Zhu","year":"2008","journal-title":"J. Infect. Dis."}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26001768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26001768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:18:41Z","timestamp":1793449121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X26001768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1995820X26001768"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2026.09.014","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A dual-glycoprotein-targeting bispecific nanoantibody confers potent neutralization against Nipah virus","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2026.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}